+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Oncology NGS Market by Technology (Amplicon-based, Hybridization-based, Targeted & Gene Panel Sequencing), Product & Service (Platforms & Related Products, Services), Application - Forecast 2024-2030- Product Image
Global Oncology NGS Market by Technology (Amplicon-based, Hybridization-based, Targeted & Gene Panel Sequencing), Product & Service (Platforms & Related Products, Services), Application - Forecast 2024-2030- Product Image
Sale

Global Oncology NGS Market by Technology (Amplicon-based, Hybridization-based, Targeted & Gene Panel Sequencing), Product & Service (Platforms & Related Products, Services), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 193 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5715540
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Oncology NGS Market size was estimated at USD 438.26 million in 2023, USD 504.37 million in 2024, and is expected to grow at a CAGR of 15.48% to reach USD 1,200.39 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Oncology NGS Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Oncology NGS Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Oncology NGS Market, highlighting leading vendors and their innovative profiles. These include 4basecare Onco Solutions Private Limited, BGI Group, Caris Life Sciences, Eurofins Scientific SE, Foundation Medicine, Inc., Genotypic Technology Pvt. Ltd., Hologic, Inc., MedGenome, Myriad Genetics, Inc., PerkinElmer Inc., Premas Life Sciences, Sayre Therapeutics Pvt Ltd., SciGenom Labs Pvt. Ltd., Tecan Trading AG, Vela Diagnostics Holding Pte Ltd., and Xcelris Labs Ltd.

Market Segmentation & Coverage

This research report categorizes the Oncology NGS Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Amplicon-based
    • Hybridization-based
    • Targeted & Gene Panel Sequencing
    • Whole Exome Sequencing
    • Whole Genome Sequencing
  • Product & Service
    • Platforms & Related Products
      • Consumables
      • Panels
      • Platforms
    • Services
      • By Workflow
      • NGS Data Analysis
      • NGS Pre-Sequencing
      • NGS Primary Data Analysis
      • NGS Secondary Data Analysis
      • NGS Sequencing
      • NGS Tertiary Data Analysis
  • Application
    • Academic & Clinical Research
    • Hospitals & Clinics
    • Pharma & Biotech Entities
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Oncology NGS Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Oncology NGS Market?
  3. What are the technology trends and regulatory frameworks in the Oncology NGS Market?
  4. What is the market share of the leading vendors in the Oncology NGS Market?
  5. Which modes and strategic moves are suitable for entering the Oncology NGS Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Oncology NGS Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Potential demand attributed to rising prevalence of cancer incidence globally
5.1.1.2. Growing popularity of personalized medicine in clinical oncology
5.1.1.3. Increasing consumer adoption owing to decreasing costs for genetic sequencing solutions
5.1.2. Restraints
5.1.2.1. Lack of computational efficiency for data management
5.1.3. Opportunities
5.1.3.1. Rising governmental initiatives and investments in the field of research and development in oncology
5.1.3.2. Emerging advancements for whole-genome sequencing worldwide
5.1.4. Challenges
5.1.4.1. Limited and inadequate reimbursement policies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Oncology NGS Market, by Technology
6.1. Introduction
6.2. Amplicon-based
6.3. Hybridization-based
6.4. Targeted & Gene Panel Sequencing
6.5. Whole Exome Sequencing
6.6. Whole Genome Sequencing
7. Oncology NGS Market, by Product & Service
7.1. Introduction
7.2. Platforms & Related Products
7.3.1. Consumables
7.3.2. Panels
7.3.3. Platforms
7.3. Services
7.4.1. By Workflow
7.4.2. NGS Data Analysis
7.4.3. NGS Pre-Sequencing
7.4.4. NGS Primary Data Analysis
7.4.5. NGS Secondary Data Analysis
7.4.6. NGS Sequencing
7.4.7. NGS Tertiary Data Analysis
8. Oncology NGS Market, by Application
8.1. Introduction
8.2. Academic & Clinical Research
8.3. Hospitals & Clinics
8.4. Pharma & Biotech Entities
9. Americas Oncology NGS Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Oncology NGS Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Oncology NGS Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 4basecare Onco Solutions Private Limited
13.1.2. BGI Group
13.1.3. Caris Life Sciences
13.1.4. Eurofins Scientific SE
13.1.5. Foundation Medicine, Inc.
13.1.6. Genotypic Technology Pvt. Ltd.
13.1.7. Hologic, Inc.
13.1.8. MedGenome
13.1.9. Myriad Genetics, Inc.
13.1.10. PerkinElmer Inc.
13.1.11. Premas Life Sciences
13.1.12. Sayre Therapeutics Pvt Ltd.
13.1.13. SciGenom Labs Pvt. Ltd.
13.1.14. Tecan Trading AG
13.1.15. Vela Diagnostics Holding Pte Ltd.
13.1.16. Xcelris Labs Ltd.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. ONCOLOGY NGS MARKET RESEARCH PROCESS
FIGURE 2. ONCOLOGY NGS MARKET SIZE, 2023 VS 2030
FIGURE 3. ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ONCOLOGY NGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ONCOLOGY NGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ONCOLOGY NGS MARKET DYNAMICS
FIGURE 7. ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
FIGURE 10. ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ONCOLOGY NGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ONCOLOGY NGS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. ONCOLOGY NGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 6. ONCOLOGY NGS MARKET SIZE, BY AMPLICON-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ONCOLOGY NGS MARKET SIZE, BY HYBRIDIZATION-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ONCOLOGY NGS MARKET SIZE, BY TARGETED & GENE PANEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ONCOLOGY NGS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ONCOLOGY NGS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 12. ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 14. ONCOLOGY NGS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ONCOLOGY NGS MARKET SIZE, BY PANELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ONCOLOGY NGS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 19. ONCOLOGY NGS MARKET SIZE, BY BY WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. ONCOLOGY NGS MARKET SIZE, BY NGS DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. ONCOLOGY NGS MARKET SIZE, BY NGS PRE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. ONCOLOGY NGS MARKET SIZE, BY NGS PRIMARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. ONCOLOGY NGS MARKET SIZE, BY NGS SECONDARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. ONCOLOGY NGS MARKET SIZE, BY NGS SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. ONCOLOGY NGS MARKET SIZE, BY NGS TERTIARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. ONCOLOGY NGS MARKET SIZE, BY ACADEMIC & CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. ONCOLOGY NGS MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. CANADA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 48. CANADA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 49. CANADA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 50. CANADA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. MEXICO ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 54. MEXICO ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 55. MEXICO ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. CHINA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. CHINA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 75. CHINA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 76. CHINA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 77. CHINA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. INDIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. INDIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 80. INDIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 81. INDIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 82. INDIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. JAPAN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. JAPAN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 90. JAPAN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 91. JAPAN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 92. JAPAN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. THAILAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. THAILAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 120. THAILAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 121. THAILAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 122. THAILAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. DENMARK ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. DENMARK ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 136. DENMARK ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 137. DENMARK ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 138. DENMARK ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. EGYPT ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. EGYPT ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 141. EGYPT ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 142. EGYPT ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 143. EGYPT ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. FINLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. FINLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 146. FINLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 147. FINLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 148. FINLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. FRANCE ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. FRANCE ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 151. FRANCE ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 152. FRANCE ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 153. FRANCE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. GERMANY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 156. GERMANY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 157. GERMANY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 158. GERMANY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. ITALY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 166. ITALY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 167. ITALY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 168. ITALY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. NORWAY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. NORWAY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 181. NORWAY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 182. NORWAY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 183. NORWAY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. POLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. POLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 186. POLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 187. POLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 188. POLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. QATAR ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. QATAR ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 191. QATAR ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 192. QATAR ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 193. QATAR ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. SPAIN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. SPAIN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 211. SPAIN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 212. SPAIN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 213. SPAIN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. TURKEY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 226. TURKEY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 227. TURKEY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 228. TURKEY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. ONCOLOGY NGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 240. ONCOLOGY NGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 241. ONCOLOGY NGS MARKET LICENSE & PRICING

Companies Mentioned

  • 4basecare Onco Solutions Private Limited
  • BGI Group
  • Caris Life Sciences
  • Eurofins Scientific SE
  • Foundation Medicine, Inc.
  • Genotypic Technology Pvt. Ltd.
  • Hologic, Inc.
  • MedGenome
  • Myriad Genetics, Inc.
  • PerkinElmer Inc.
  • Premas Life Sciences
  • Sayre Therapeutics Pvt Ltd.
  • SciGenom Labs Pvt. Ltd.
  • Tecan Trading AG
  • Vela Diagnostics Holding Pte Ltd.
  • Xcelris Labs Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages193
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 504.37 Million
Forecasted Market Value ( USD ) by 2030 $ 1200.39 Million
Compound Annual Growth Rate15.4%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Workflow (NGS Pre-sequencing, NGS Data Analysis), By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2023-2030 - Product Image

Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Workflow (NGS Pre-sequencing, NGS Data Analysis), By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2023-2030

  • Report
  • 180 Pages
  • Global
From
Global NGS Data Storage Market by Sourcing Type (In-house NGS Data Storage, Outsourced NGS Data Storage), Offerings (Cloud-based Solutions, Data Analysis Services, Data Storage Solutions), Application, End-user - Forecast 2024-2030 - Product Image

Global NGS Data Storage Market by Sourcing Type (In-house NGS Data Storage, Outsourced NGS Data Storage), Offerings (Cloud-based Solutions, Data Analysis Services, Data Storage Solutions), Application, End-user - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Next Generation Sequencing (NGS) Market - A Global and Regional Analysis: Focus on Offering, Company, Throughput, Technology Type, Sequencing, Application, End User, and Country Analysis - Analysis and Forecast, 2023-2033 - Product Image

Next Generation Sequencing (NGS) Market - A Global and Regional Analysis: Focus on Offering, Company, Throughput, Technology Type, Sequencing, Application, End User, and Country Analysis - Analysis and Forecast, 2023-2033

  • Report
  • 385 Pages
  • Global
From
Global Next-Generation Sequencing Sample Preparation Market by Workflow (Automated Library Preparation, Clonal Amplification, NGS Library Preparation Kits), Application (Agrigenomics & Forensics, Clinical Investigation, Consumer Genomics), End User - Forecast 2024-2030 - Product Image

Global Next-Generation Sequencing Sample Preparation Market by Workflow (Automated Library Preparation, Clonal Amplification, NGS Library Preparation Kits), Application (Agrigenomics & Forensics, Clinical Investigation, Consumer Genomics), End User - Forecast 2024-2030

  • Report
  • 193 Pages
  • Global
From
NGS Data Storage Market - A Global and Regional Analysis: Focus on Offerings, Read Length, Sourcing Type, Application, End User, and Country Analysis - Analysis and Forecast, 2023-2033 - Product Image

NGS Data Storage Market - A Global and Regional Analysis: Focus on Offerings, Read Length, Sourcing Type, Application, End User, and Country Analysis - Analysis and Forecast, 2023-2033

  • Report
  • 201 Pages
  • Global
From

About the Market

The Oncology NGS market is a subset of the biotechnology industry that focuses on the development of technologies and products related to the diagnosis and treatment of cancer. This includes the use of next-generation sequencing (NGS) to identify genetic mutations in cancer cells, as well as the development of targeted therapies and immunotherapies to treat cancer. NGS is a powerful tool for cancer research, as it can provide a comprehensive view of the genetic makeup of a tumor, allowing for more accurate diagnosis and treatment. The Oncology NGS market is highly competitive, with a number of companies offering products and services related to cancer diagnosis and treatment. These include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and Qiagen. Additionally, there are a number of smaller companies that specialize in specific areas of oncology NGS, such as bioinformatics, data analysis, and drug development. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.